Literature DB >> 23988395

Evaluation of the short-term executive plus intervention for executive dysfunction after traumatic brain injury: a randomized controlled trial with minimization.

Joshua Cantor1, Teresa Ashman1, Kristen Dams-O'Connor1, Marcel P Dijkers1, Wayne Gordon2, Lisa Spielman1, Theodore Tsaousides1, Hafina Allen1, Michael Nguyen1, Jennifer Oswald1.   

Abstract

OBJECTIVE: To determine whether the Short-Term Executive Plus (STEP) cognitive rehabilitation program improves executive dysfunction after traumatic brain injury (TBI).
DESIGN: Randomized, waitlist controlled trial with minimization and blinded outcome assessment.
SETTING: Community. PARTICIPANTS: Participants with TBI and executive dysfunction (N=98; TBI severity 50% moderate/severe; mean time since injury ± SD, 12±14y; mean age ± SD, 45±14y; 62% women; 76% white). INTERVENTION: STEP program: 12 weeks (9h/wk) of group training in problem solving and emotional regulation and individual sessions of attention and compensatory strategies training. MAIN OUTCOME MEASURES: Factor analysis was used to create a composite executive function measure using the Problem Solving Inventory, Frontal Systems Behavior Scale, Behavioral Assessment of the Dysexecutive Syndrome, and Self-Awareness of Deficits Interview. Emotional regulation was assessed with the Difficulties in Emotion Regulation Scale. The primary attention measure was the Attention Rating and Monitoring Scale. Secondary measures included neuropsychological measures of executive function, attention, and memory and measures of affective distress, self-efficacy, social participation, and quality of life.
RESULTS: Intention-to-treat mixed-effects analyses revealed significant treatment effects for the composite executive function measure (P=.008) and the Frontal Systems Behavior Scale (P=.049) and Problem Solving Inventory (P=.016). We found no between-group differences on the neuropsychological measures or on measures of attention, emotional regulation, self-awareness, affective distress, self-efficacy, participation, or quality of life.
CONCLUSIONS: The STEP program is efficacious in improving self-reported post-TBI executive function and problem solving. Further research is needed to identify the roles of the different components of the intervention and its effectiveness with different TBI populations.
Copyright © 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APT-II; Attention Process Training, Second Edition; Brain injuries; Brain injury, chronic; Cognition disorders; Cognitive therapy; FrSBe; Frontal Systems Behavior Scale; Rehabilitation; STEP; Short-Term Executive Plus; TBI; WCST; WL; Wisconsin Card Sorting Test computer version 4; traumatic brain injury; waitlist

Mesh:

Year:  2013        PMID: 23988395     DOI: 10.1016/j.apmr.2013.08.005

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  13 in total

Review 1.  Cognitive rehabilitation for adults with traumatic brain injury to improve occupational outcomes.

Authors:  K Suresh Kumar; Selvaraj Samuelkamaleshkumar; Anand Viswanathan; Ashish S Macaden
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Factors associated with cognitive impairment in a cohort of older homeless adults: Results from the HOPE HOME study.

Authors:  Emily Hurstak; Julene K Johnson; Lina Tieu; David Guzman; Claudia Ponath; Christopher T Lee; Christina Weyer Jamora; Margot Kushel
Journal:  Drug Alcohol Depend       Date:  2017-07-04       Impact factor: 4.492

3.  Reductions in Alexithymia and Emotion Dysregulation After Training Emotional Self-Awareness Following Traumatic Brain Injury: A Phase I Trial.

Authors:  Dawn Neumann; James F Malec; Flora M Hammond
Journal:  J Head Trauma Rehabil       Date:  2017 Sep/Oct       Impact factor: 2.710

4.  Factor structure and item level psychometrics of the Social Problem Solving Inventory-Revised: Short Form in traumatic brain injury.

Authors:  Chih-Ying Li; Julia Waid-Ebbs; Craig A Velozo; Shelley C Heaton
Journal:  Neuropsychol Rehabil       Date:  2015-06-08       Impact factor: 2.868

5.  Screening for traumatic brain injury: findings and public health implications.

Authors:  Kristen Dams-OʼConnor; Joshua B Cantor; Margaret Brown; Marcel P Dijkers; Lisa A Spielman; Wayne A Gordon
Journal:  J Head Trauma Rehabil       Date:  2014 Nov-Dec       Impact factor: 2.710

6.  Implementation of a Mobile Technology-Supported Diaphragmatic Breathing Intervention in Military mTBI With PTSD.

Authors:  Tracey Wallace; John T Morris; Richard Glickstein; Raeda K Anderson; Russell K Gore
Journal:  J Head Trauma Rehabil       Date:  2022 May-Jun 01       Impact factor: 3.117

7.  Young Adults With Acquired Brain Injury Show Longitudinal Improvements in Cognition After Intensive Cognitive Rehabilitation.

Authors:  Natalie Gilmore; Daniel Mirman; Swathi Kiran
Journal:  J Speech Lang Hear Res       Date:  2022-03-15       Impact factor: 2.674

8.  Mindful creativity matters: trajectories of reported functioning after severe traumatic brain injury as a function of mindful creativity in patients' relatives: a multilevel analysis.

Authors:  Chiara S Haller; Colin M Bosma; Kush Kapur; Ross Zafonte; Ellen J Langer
Journal:  Qual Life Res       Date:  2016-09-23       Impact factor: 4.147

9.  Cognitive Rehabilitation With Mobile Technology and Social Support for Veterans With TBI and PTSD: A Randomized Clinical Trial.

Authors:  Eric B Elbogen; Paul A Dennis; Elizabeth E Van Voorhees; Shannon M Blakey; Jacqueline L Johnson; Sally C Johnson; H Ryan Wagner; Robert M Hamer; Jean C Beckham; Tom Manly; Aysenil Belger
Journal:  J Head Trauma Rehabil       Date:  2019 Jan/Feb       Impact factor: 2.710

10.  Cognitive Training for Post-Acute Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Authors:  Harry Hallock; Daniel Collins; Amit Lampit; Kiran Deol; Jennifer Fleming; Michael Valenzuela
Journal:  Front Hum Neurosci       Date:  2016-10-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.